Inspire Medical Systems, Inc. (INSP) Payables and obligations
- Other obligations · latest quarter (USD): Value (m); Formula and calculation Total liabilities − borrowing debt − payables − total deferred revenue. Includes accruals, taxes, leases and other obligations; excludes the separately shown balances. Period ending 2026-06-30..
- Payables · latest quarter (USD): Value (m); Formula and calculation Amounts owed to suppliers, reported accounts payable. Period ending 2026-06-30..
- Deferred revenue · latest quarter (USD): Value (m); Formula and calculation Current and noncurrent customer contract obligations; payments received before revenue is earned. Period ending 2026-06-30..
- Other obligations · due within 1 year (USD): Value (m); Formula and calculation Reported other current liabilities. Excludes separately reported debt, payables and current deferred revenue. The saved current-quarter facts do not separately disclose taxes, payroll, leases or accruals. Period ending 2026-06-30..
Payables and obligations
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Other obligations · latest quarter (USD) | (m) | Total liabilities − borrowing debt − payables − total deferred revenue. Includes accruals, taxes, leases and other obligations; excludes the separately shown balances. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Payables · latest quarter (USD) | (m) | Amounts owed to suppliers, reported accounts payable. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Deferred revenue · latest quarter (USD) | (m) | Current and noncurrent customer contract obligations; payments received before revenue is earned. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Other obligations · due within 1 year (USD) | (m) | Reported other current liabilities. Excludes separately reported debt, payables and current deferred revenue. The saved current-quarter facts do not separately disclose taxes, payroll, leases or accruals. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Other obligations · due after 1 year (USD) | (m) | Reported other noncurrent liabilities minus the noncurrent deferred revenue they include (total customer contract obligations − current portion); a separately reported noncurrent deferred revenue line is not deducted. The saved current-quarter facts do not separately disclose taxes, leases or other accruals. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Total reported obligations | 100.41M USD | Liabilities |
| Borrowing debt | (m) | |
| Amounts owed to suppliers | (m) | |
| Total deferred revenue | (m) | |
| Deferred revenue due within one year | (m) | |
| Deferred revenue due after one year | (m) | |
| Reported other obligations due within one year | (m) | |
| Reported other noncurrent obligations | 136.00K USD | Other Liabilities, Noncurrent |
| Deferred revenue included in other noncurrent obligations | (m) |
Other obligations breakdown
- Other obligations · due within 1 year (USD)
- (m)
- Other obligations · due after 1 year (USD)
- (m)
Bonds and commercial paper are already included in Total debt. Other obligations include taxes, accrued expenses and operating/finance leases. Category amounts below are the issuer’s own tagged balances at the same quarter end; untagged categories are not shown.
| Category | Quarter ending 2026-06-30 |
|---|---|
| Obligation categories | (m) |
These categories are parts of the combined obligations, not additional deductions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Other obligations | Payables | Deferred revenue | Short-term obligations | Long-term obligations | Total reported obligations (USD) | Borrowing debt (USD) | Deferred revenue due within one year (USD) | Deferred revenue due after one year (USD) | Reported other noncurrent obligations (USD) | Deferred revenue included in other noncurrent obligations (USD) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | (m) | (m) | (m) | (m) | $100.41M | (m) | (m) | (m) | $136.00K | (m) |
| 2026-03-31 | (m) | (m) | (m) | (m) | (m) | $119.04M | (m) | (m) | (m) | $66.00K | (m) |
| 2025-12-31 | (m) | (m) | (m) | (m) | (m) | $126.16M | (m) | (m) | (m) | $104.00K | (m) |
| 2025-09-30 | (m) | (m) | (m) | (m) | (m) | $141.26M | (m) | (m) | (m) | $111.00K | (m) |
| 2025-06-30 | (m) | (m) | (m) | (m) | (m) | $124.38M | (m) | (m) | (m) | $111.00K | (m) |
| 2025-03-31 | (m) | (m) | (m) | (m) | (m) | $95.07M | (m) | (m) | (m) | $108.00K | (m) |
| 2024-12-31 | (m) | (m) | (m) | (m) | (m) | $118.69M | (m) | (m) | (m) | $148.00K | (m) |
| 2024-09-30 | (m) | (m) | (m) | (m) | (m) | $99.63M | (m) | (m) | (m) | $150.00K | (m) |
| 2024-06-30 | (m) | (m) | (m) | (m) | (m) | $90.32M | (m) | (m) | (m) | $149.00K | (m) |
| 2024-03-31 | (m) | (m) | (m) | (m) | (m) | $96.82M | (m) | (m) | (m) | $146.00K | (m) |
| 2023-12-31 | (m) | (m) | (m) | (m) | (m) | $104.30M | (m) | (m) | (m) | $1.35M | (m) |
| 2023-09-30 | (m) | (m) | (m) | (m) | (m) | $95.31M | (m) | (m) | (m) | $146.00K | (m) |
| 2023-06-30 | (m) | (m) | (m) | (m) | (m) | $88.89M | (m) | (m) | (m) | $146.00K | (m) |
| 2023-03-31 | (m) | (m) | (m) | (m) | (m) | $67.20M | (m) | (m) | (m) | $146.00K | (m) |
| 2022-12-31 | (m) | (m) | (m) | (m) | (m) | $68.87M | (m) | (m) | (m) | $146.00K | (m) |
| 2022-09-30 | (m) | (m) | (m) | (m) | (m) | $57.32M | (m) | (m) | (m) | $146.00K | (m) |
| 2022-06-30 | (m) | (m) | (m) | (m) | (m) | $65.02M | (m) | (m) | (m) | $146.00K | (m) |
| 2022-03-31 | (m) | (m) | (m) | (m) | (m) | $64.67M | (m) | (m) | (m) | $146.00K | (m) |
| 2021-12-31 | (m) | (m) | (m) | (m) | (m) | $66.04M | (m) | (m) | (m) | $134.00K | (m) |
| 2021-09-30 | (m) | (m) | (m) | (m) | (m) | $58.59M | (m) | (m) | (m) | $124.00K | (m) |
| 2021-06-30 | (m) | (m) | (m) | (m) | (m) | $52.29M | (m) | (m) | (m) | $111.00K | (m) |
| 2021-03-31 | (m) | (m) | (m) | (m) | (m) | $50.28M | (m) | (m) | (m) | $97.00K | (m) |
| 2020-12-31 | (m) | (m) | (m) | (m) | (m) | $51.44M | (m) | (m) | (m) | $85.00K | (m) |
| 2020-09-30 | (m) | (m) | (m) | (m) | (m) | $42.96M | (m) | (m) | (m) | $74.00K | (m) |
| 2020-06-30 | (m) | (m) | (m) | (m) | (m) | $37.71M | (m) | (m) | (m) | $40.00K | (m) |
| 2020-03-31 | (m) | (m) | (m) | (m) | (m) | $38.33M | (m) | (m) | (m) | $40.00K | (m) |
| 2019-12-31 | (m) | (m) | (m) | (m) | (m) | $41.42M | (m) | (m) | (m) | $40.00K | (m) |
| 2019-09-30 | (m) | (m) | (m) | (m) | (m) | $37.17M | (m) | (m) | (m) | (m) | (m) |
| 2019-06-30 | (m) | (m) | (m) | (m) | (m) | $33.08M | (m) | (m) | (m) | (m) | (m) |
| 2019-03-31 | (m) | (m) | (m) | (m) | (m) | $32.19M | (m) | (m) | (m) | (m) | (m) |
| 2019-01-01 | (m) | (m) | (m) | (m) | (m) | $36.09M | (m) | (m) | (m) | (m) | (m) |
| 2018-12-31 | (m) | (m) | (m) | (m) | (m) | $36.08M | (m) | (m) | (m) | (m) | (m) |
| 2017-12-31 | (m) | (m) | (m) | (m) | (m) | $23.76M | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |